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論文の要旨 
Abstract of thesis 
Background 
Sleep-wake cycle is an intricate process controlled by complex cascade of effectors. The homeostatic propensity to 
sleep increases as “sleep need” accumulates during wakeful state, driving animals to commence in sleep behavior. 
However, the molecular and cellular mechanism that facilitates such switch is largely unknown. Forward genetic 
screening based on a heritable phenotype is useful for searching the causal genetic change without requiring a 
specific working hypothesis. 
 
Purpose 
The ENU-driven mutagenesis screen by the Yanagisawa’s group is the world’s first unbiased (non-candidate 
gene-based) attempt to causally identify regulatory genes in the sleep physiology in mice. The advantages of sleep 
research using mice over fruit fly include reliable staging of three vigilance states, wakefulness, NREMS and 
REMS through EEG/EMG-based somnography analysis. Furthermore, the high similarity of the genome and brain 
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 structure between mouse and human predicts a conserved mechanism regulating sleep/wakefulness. The applicant 
et al expected that findings in mice can be directly applied to human sleep physiology and pathology, and sought to 
understand the pathway that governs the sleep regulation with attempts to identify key factors in the regulatory 
cascade.  
 
Materials and Methods 
First, C57BL/6J G0 male mice were treated with ENU at 100 mg/kg body weight at weekly interval for three weeks. 
At age of 25-30 weeks, sperms were collected from the G0 male mice for in vitro fertilization with C57BL/6N 
female eggs to produce F1 offspring. A comprehensive set of sleep parameters is measured in the F1 male progeny 
through EEG/EMG-based somnography analysis. Each F1 showing perturbed sleep behavior was selected as 
founder for mutant pedigree and proceeded for N2 offspring production by either natural mating or in vitro 
fertilization with C57BL/6N female. The established mutant pedigree is, then, subjected to heritability test and 
genetic identification by linkage analysis and whole exome sequencing. 
 
Result 
ENU induces ~3000 mutations randomly across the genome per gamete in ENU-treated G0 mice. Since their 
progeny of F1 and N2 still carries hundreds of random mutations that may have inherited from the founder mice, 
the causality between the mapped gene mutation and observed phenotype must be shown. Traditionally, counter 
strains genetically very distant from the mutagenized strain were preferred because polymorphic markers were 
more readily available. However, the availability of the complete mouse genome sequences with genome-wide list 
of genetic markers between C57BL/6J (B6J) and C57BL/6N (B6N), together with the next-generation sequencing, 
has made use of such distant counter strains and fine-grained linkage analyses unnecessary. To evaluate the 
similarity in sleep and wake behavior between B6J and B6N, two strains against C57BL/10J were examined. 
Consistent with the genetic proximity, B6J and B6N showed similar sleep/wakefulness compared to B10J. Thus, 
based on their near-identical sleep/wake behavior, C57BL/6J and C57BL/6N are chosen as mutagenized and 
counter strains, respectively. The reproducibility of the sleep/wake parameters were also examined by recording the 
same animal twice in 4+ weeks interval. Among the parameters tested, the total time spent in the wake and 
non-rapid eye movement (NREMS), as well as the REMS episode duration, show sufficient reproducibility with 
small coefficients of variance, indicating that these parameters are most suitable for quantitative phenotype-driven 
screening. This is consistent with our previous finding that Sik3Sleepy mutant and NalcnDreamless mutant pedigrees 
were isolated based on total wake/NREM sleep time and REM sleep episode duration, respectively. Whole-exome 
sequencing combined with coarse linkage analyses can immediately provide a list of candidate gene mutations 
associated with sleep abnormality. Our simulations calculate the achievable LOD score as a function of the 
 phenotype strength and the numbers of mice examined. With the advances in genome sequencing capabilities and 
the nuclease-mediated targeted mutagenesis system, the major obstacles of time and cost for genetic validation is 
greatly reduced. The system successfully identified Sleepy and Dreamless pedigrees with abnormal sleep/wake 
behavior as reported by Funato et al in Nature (2016). Here, a pedigree with a mild decrease in total wake time 
linked to a mutation in the Cacna1a gene is presented as an example.  
 
Discussion 
Our screening at ~10,000 scales succeeded in finding 10 heritable loci and identified 3 causal gene mutations 
linked to sleep abnormalities. While low occurrence of sleep phenodeviant was expected, possibly due to redundant 
regulatory mechanisms in sleep/wakefulness and low penetrance of the phenotype, our screening output seems to 
be comparable to other trials where a single biological trait is screened. The identified genes in the study usually 
encode proteins with large molecular weights, probably because the cumulative frequency of ENU-induced 
mutation is proportional to the gene size; some of known sleep regulatory genes, such as the very compact orexin 
and orexin receptor genes, have not been detected in this screening. Also, for unknown reasons, the majority of our 
sleep phenodeviants has been long-sleep mutants. Phenotype-driven screening at such large scale, indeed, is 
labor-intensive and costly. It is not recommended for an attempt to furthering the knowledge of largely defined 
mechanisms since there is a high chance of identifying already known genes, as it was the case of our obesity 
screening. Also, in a dominant screening, a highly focused screen is recommend rather than trying to examine 
multiple biological traits in a workflow; after all, the most expensive step in the screening is phenotyping, not the 
production of mutagenized mice. It is difficult to draw estimation on further identification of candidate genes and 
whether/when saturation can be reached in a dominant screen. Nevertheless, more causal gene mutations in 
sleep/wake regulation is expected to be found by enlarging the scale and continuing the search. The screening 
strategy is easily modifiable for studying other physiological phenomena in mice with careful selection of the 
screening criteria and the biology to be studied. 
 
審査の要旨 
 Abstract of assessment result 
 
【批評 Review】 
Sleep-wake cycle is an intricate process controlled by complex cascade of effectors. However, the molecular and 
cellular mechanism that facilitates such switch is largely unknown. The applicant described the optimized 
streamline of dominant screening of randomly mutagenized mice in sleep and wake behavior, which had led to 
successful identification of multiple mutations responsible for strong sleep/wake phenotype. By using the forward 
genetic screening based on a heritable phenotype, the applicant successfully identified more candidate genes, 
 including Cacna1a showing a mild decrease in total wake time resulting from a heterozygous mutation. In 
conclusion, the applicant demonstrated that their screening system is modifiable for application in any behavioral 
analysis other than sleep/wakefulness. 
 
 
【最終試験の結果 Result】 
The final examination committee conducted a meeting as a final examination on July 2nd, 2019. The applicant 
provided an overview of dissertation, addressed questions and comments raised during Q&A session. All of the 
committee members reached a final decision that the applicant has passed the final examination. 
 
 
【結論 Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be awarded a Doctor of 
Philosophy in Human Biology. 
